Showing results (41-50 of 156) with videos related to
Sort By:
Pageof 16
Journal of Chemical Information and Modeling|October 2, 2008
Targeting the conformational transitions of MDM2 and MDMX: insights into dissimilarities and similarities of p53 recognitionAntonio Macchiarulo, Nicola Giacchè, Andrea Carotti, et al.Expert Opinion on Drug Discovery|August 8, 2019
Preclinical discovery and development of fingolimod for the treatment of multiple sclerosisClaudia Volpi, Ciriana Orabona, Antonio Macchiarulo, et al.Chemmedchem|June 17, 2021
One Key and Multiple Locks: Substrate Binding in Structures of Tryptophan Dioxygenases and HydroxylasesAndrea Mammoli, Alessandra Riccio, Elisa Bianconi, et al.Current Topics in Medicinal Chemistry|November 13, 2014
Bile acid derivatives as ligands of the farnesoid x receptor: molecular determinants for bile acid binding and receptor modulationAntimo Gioiello, Bruno Cerra, Serena Mostarda, et al.Bioorganic & Medicinal Chemistry|September 6, 2002
1,4-Benzothiazine and 1,4-benzoxazine imidazole derivatives with antifungal activity: a docking studyAntonio Macchiarulo, Gabriele Costantino, Daniele Fringuelli, et al.Bioorganic & Medicinal Chemistry|October 6, 2024
Rational design, synthesis, and biophysical characterization of a peptidic MDM2-MDM4 interaction inhibitorMarco Ballarotto, Elisa Bianconi, Sonia Valentini, et al.Bioorganic & Medicinal Chemistry Letters|October 27, 2004
Homology model of the multidrug transporter LmrA from Lactococcus lactisKarin Pleban, Antonio Macchiarulo, Gabriele Costantino, et al.Molecular and Cellular Biology|October 23, 2002
Glucocorticoid-induced leucine zipper inhibits the Raf-extracellular signal-regulated kinase pathway by binding to Raf-1Emira Ayroldi, Ornella Zollo, Antonio Macchiarulo, et al.Journal of Medicinal Chemistry|November 24, 2005
Design, synthesis, and microbiological evaluation of new Candida albicans CYP51 inhibitorsFausto Schiaffella, Antonio Macchiarulo, Lara Milanese, et al.Farmaco (Societa Chimica Italiana : 1989)|September 19, 2003
Towards new neuroprotective agents: design and synthesis of 4H-thieno[2,3-c] isoquinolin-5-one derivatives as potent PARP-1 inhibitorsRoberto Pellicciari, Emidio Camaioni, Gabriele Costantino, et al.Pageof 16